402 related articles for article (PubMed ID: 10448862)
1. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.
Musarò A; McCullagh KJ; Naya FJ; Olson EN; Rosenthal N
Nature; 1999 Aug; 400(6744):581-5. PubMed ID: 10448862
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle hypertrophy is mediated by a Ca2+-dependent calcineurin signalling pathway.
Semsarian C; Wu MJ; Ju YK; Marciniec T; Yeoh T; Allen DG; Harvey RP; Graham RM
Nature; 1999 Aug; 400(6744):576-81. PubMed ID: 10448861
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-2.
Sakuma K; Nishikawa J; Nakao R; Watanabe K; Totsuka T; Nakano H; Sano M; Yasuhara M
Acta Neuropathol; 2003 Mar; 105(3):271-80. PubMed ID: 12557015
[TBL] [Abstract][Full Text] [Related]
4. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle.
Musarò A; McCullagh K; Paul A; Houghton L; Dobrowolny G; Molinaro M; Barton ER; Sweeney HL; Rosenthal N
Nat Genet; 2001 Feb; 27(2):195-200. PubMed ID: 11175789
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF-AT pathway.
St-Pierre SJ; Chakkalakal JV; Kolodziejczyk SM; Knudson JC; Jasmin BJ; Megeney LA
FASEB J; 2004 Dec; 18(15):1937-9. PubMed ID: 15456738
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
7. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
8. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
Rommel C; Bodine SC; Clarke BA; Rossman R; Nunez L; Stitt TN; Yancopoulos GD; Glass DJ
Nat Cell Biol; 2001 Nov; 3(11):1009-13. PubMed ID: 11715022
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor MEF2C mediates cardiomyocyte hypertrophy induced by IGF-1 signaling.
Muñoz JP; Collao A; Chiong M; Maldonado C; Adasme T; Carrasco L; Ocaranza P; Bravo R; Gonzalez L; Díaz-Araya G; Hidalgo C; Lavandero S
Biochem Biophys Res Commun; 2009 Oct; 388(1):155-60. PubMed ID: 19654000
[TBL] [Abstract][Full Text] [Related]
10. Remodeling muscles with calcineurin.
Olson EN; Williams RS
Bioessays; 2000 Jun; 22(6):510-9. PubMed ID: 10842305
[TBL] [Abstract][Full Text] [Related]
11. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
[TBL] [Abstract][Full Text] [Related]
12. Hypertrophy and transcriptional regulation induced in myogenic cell line L6-C5 by an increase of extracellular calcium.
De Arcangelis V; Coletti D; Canato M; Molinaro M; Adamo S; Reggiani C; Naro F
J Cell Physiol; 2005 Mar; 202(3):787-95. PubMed ID: 15389566
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor (IGF-I) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell model.
Semsarian C; Sutrave P; Richmond DR; Graham RM
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):443-51. PubMed ID: 10191278
[TBL] [Abstract][Full Text] [Related]
14. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.
Lim HW; De Windt LJ; Mante J; Kimball TR; Witt SA; Sussman MA; Molkentin JD
J Mol Cell Cardiol; 2000 Apr; 32(4):697-709. PubMed ID: 10756124
[TBL] [Abstract][Full Text] [Related]
15. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
Fiedler B; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
[TBL] [Abstract][Full Text] [Related]
16. Calcineurin and skeletal muscle growth.
Michel RN; Dunn SE; Chin ER
Proc Nutr Soc; 2004 May; 63(2):341-9. PubMed ID: 15294053
[TBL] [Abstract][Full Text] [Related]
17. Effect of moderate acute exercise on expression of mRNA involved in the calcineurin signaling pathway in human skeletal muscle.
Hitomi Y; Kizaki T; Katsumura T; Mizuno M; Itoh CE; Esaki K; Fujioka Y; Takemasa T; Haga S; Ohno H
IUBMB Life; 2003 Jul; 55(7):409-13. PubMed ID: 14584592
[TBL] [Abstract][Full Text] [Related]
18. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum.
de la Pompa JL; Timmerman LA; Takimoto H; Yoshida H; Elia AJ; Samper E; Potter J; Wakeham A; Marengere L; Langille BL; Crabtree GR; Mak TW
Nature; 1998 Mar; 392(6672):182-6. PubMed ID: 9515963
[TBL] [Abstract][Full Text] [Related]
19. Type I insulin-like growth factor receptor signaling in skeletal muscle regeneration and hypertrophy.
Philippou A; Halapas A; Maridaki M; Koutsilieris M
J Musculoskelet Neuronal Interact; 2007; 7(3):208-18. PubMed ID: 17947802
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
